Braveheart Bio, Inc. (BRVE) Live Share Price, Invest From India

Braveheart Bio, Inc. Stock Performance

as on September 15, 2026 at 2:16 pm IST

Day's Low
Day's High
$26.31
Day's Price Range
$27.76
$27.02
2.63%
Downside
2.74%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$27.02
100.00%
Downside
-100.00%
Upside

Braveheart Bio, Inc. share price movements today

Previous Close: $26.64
Open: $27.49
Volume: 340.9K
Market Cap: $2.4B
Day's Low - High: $26.31 - $27.76

Braveheart Bio, Inc. Historical Returns

1 Month Return: -0.04 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Braveheart Bio, Inc. Stock Fundamentals & Key Indicators

Check Braveheart Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-0.898

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Braveheart Bio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Braveheart Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Braveheart Bio, Inc.	StrongBuy	$2.4B	NA	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$130.6B	175.08%	29.76	86.04%	NA
Moderna	BUY	$57.5B	-66.24%	-18.04	-12.57%	NA
Regeneron	BUY	$80.5B	21.74%	18.95	84.86%	47.339999999999996%

Analyst Recommendation on Braveheart Bio, Inc. Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Braveheart Bio, Inc.. Average target price of $45.25

Indian Investors' Interest in Braveheart Bio, Inc. Stock

Search interest for Braveheart Bio, Inc. Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 16, 2026 to September 15, 2026

Change:3% versus previous 30 day period

Braveheart Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	0	0	-15	-15
EBITDA	-	-	-	-
Interest Expense	-	-	-	-
Depreciation	-	-	0	0
Income Before Tax	0	0	-14	-14
Income Tax Expense	-	-	-	-
Net Income	0	0	-14	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Braveheart Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-
Operating Income	-4
EBITDA	-
Interest Expense	-
Depreciation	-
Income Before Tax	-66
Income Tax Expense	-
Net Income	-66
Net Profit Margin	0.00%

Braveheart Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Mar 2026	Jun 2026
Net Income	0	-14	-14
Operating Cash Flow	-	-5	-16
Investing Cash Flow	-	-	-
Financing Cash Flow	0	0	59
Change in Cash	0	-8	42

Global Institutional Holdings in Braveheart Bio, Inc.

Funds	Holdings
Fidelity	0.01%
T. Rowe Price	0%

Insights on Braveheart Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BRVE stock has moved down by -8.1%

About Braveheart Bio, Inc.

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California.

Organisation	Braveheart Bio, Inc.
Headquarters	One Letterman Drive, San Francisco, CA, United States, 94129
Industry	Biotechnology
CEO	Dr. Travis Murdoch B.S., M.D., M.Sc.
E-voting on shares	Click here to vote

Key Management of Braveheart Bio, Inc.

Name	Title
Dr. Travis Murdoch B.S., M.D., M.Sc.	CEO, President & Director
Ms. Michele A. Anderson	Chief Development Officer
Ms. Brittany de Temple	Senior Vice President of Development Operations
Dr. Emil M. deGoma M.D.	Chief Medical Officer
Mr. Tyler Chavez Ph.D.	Chief Business Officer
Mr. James Paul Rickey CPA	Chief Financial Officer
Mr. Marc Evanchik M.S.	Chief Scientific Officer
Ms. Natalie Dement J.D.	VP & Head of Legal
Mr. Timothy Y. Zhou	Director of Corporate Development
Ms. Steph Palencia	Associate Director of Human Resources & Office Manager

FAQs

What is Braveheart Bio, Inc. share price today?

Braveheart Bio, Inc. share price today is $27.02 as on September 15, 2026 at 8:46 am IST at the close of the market. Braveheart Bio, Inc. share today touched a day high of $27.76 and a low of $26.31.

What is the 52 week high and 52 week low for Braveheart Bio, Inc. share?

Braveheart Bio, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Braveheart Bio, Inc. stock price today i.e. September 15, 2026 at 8:46 am IST is closed at $27.02,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Braveheart Bio, Inc.'s market capitalisation today?

Braveheart Bio, Inc. market capitalisation is $0.00T as on September 15, 2026 at 8:46 am IST.

How to invest in Braveheart Bio, Inc. Stock (BRVE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Braveheart Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Braveheart Bio, Inc. Shares that will get you 0.0555 shares as per Braveheart Bio, Inc. share price of $27.02 per share as on September 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Braveheart Bio, Inc. Stock (BRVE) from India?

Indian investors can start investing in Braveheart Bio, Inc. (BRVE) shares with as little as ₹95.54 or $1 (as of September 15, 2026 at 4:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Braveheart Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on September 15, 2026 at 4:37 pm IST). Based on Braveheart Bio, Inc. share’s latest price of $27.02 as on September 15, 2026 at 8:46 am IST, you will get 0.3701 shares of Braveheart Bio, Inc.. Learn more about fractional shares .